Radius Health Inc. (RDUS)

Business: Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology.

IPO Date: 06-Jun-2014

CEO, Pres & Director: Mr. G. Kelly Martin

VP of Sales & Head of U.S. Sales Channels: Ms. Danielle Holtschlag

Listing: NASDAQ: RDUS

Country: United States

Headquarters: Boston, MA

Website: https://radiuspharm.com

Market cap: $498.85 Mln

Revenue (TTM): $216.87 Mln

Earnings (TTM): $-72.70 Mln

Cash: $71.62 Mln

Total Debt: $340.14 Mln

Insider's Holding: 0.53%

Liquidity: Low

52 Week range: $4.97 - 23.00

Shares outstanding: 47,600,500

10 Years Aggregate:

• CFO: $-953.63 Mln
• EBITDA: $-1,152.36 Mln
• Net Profit: $-1,264.58 Mln